Asset Details
Do you wish to reserve the book?
Preparation, in vitro and in vivo characterization of solid dispersions of Oxcarbazepine using melting technique
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Preparation, in vitro and in vivo characterization of solid dispersions of Oxcarbazepine using melting technique
Do you wish to request the book?
Preparation, in vitro and in vivo characterization of solid dispersions of Oxcarbazepine using melting technique
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Preparation, in vitro and in vivo characterization of solid dispersions of Oxcarbazepine using melting technique
2015
Overview
Oxcarbazepine is one of the newer antiepileptic drugs and low aqueous solubility of Oxcarbazepine is responsible for its poor dissolution and delayed onset of action. The purpose of the present investigation is to increase the dissolution rate of Oxcarbazepine by preparing its solid dispersions with PEG 6000 using melting technique and subjecting the prepared solid dispersions to drug-carrier interaction, dissolution and stability studies and it was found that the dissolution rate was improved for Oxcarbazepine in its solid dispersion. As indicated from XRD and DSC studies, Oxcarbazepine was in the amorphous form in the solid dispersions, which confirmed the better dissolution rate of prepared stable solid dispersions. Pharmacokinetic profiles of Oxcarbazepine and solid dispersion were compared by one way ANOVA followed by a Dunnett Post Hoc test which indicated higher attainable plasma concentrations. Solid dispersion showed a difference with the pure drug in its pharmacokinetic profile which may be attributed to better dissolution rate of Oxcarbazepine from its solid dispersion.
Publisher
The Pharma Innovation
Subject
We currently cannot retrieve any items related to this title. Kindly check back at a later time.